Is TMDX stock a Buy, Sell, or Hold?

Based on our analysis, TMDX is currently a HOLD with low confidence. 📊 HOLD: TMDX shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

What is the fair value of TMDX stock?

Our analysis estimates the fair value range for TMDX to be between $76.77 and $86.44. The current price is $72.06.

What is the analyst price target for TMDX?

The average Wall Street analyst price target for TMDX is $98.73. This implies a potential upside of 36.4% from current levels.

TransMedics Group (TMDX) Stock: Buy, Sell, or Hold?

TMDX - TransMedics Group, Inc. Common Stock

ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS

$72.06

-0.34 (-0.47%) ▼

5d: -5.83%

30d: -17.17%

90d: -0.28%

HOLD

LOW Confidence

Protect Your TMDX Gains

Analysis Updated: Oct 22, 2026 12:00 AM ET

Earnings: Nov 04, 2026 12d

Smart Money Accumulation

Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →

Signal fired Oct 19, 2026 at $72.36 · last confirmed Oct 19, 2026

Strength: 6.5/10

Get Alerted When TMDX Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
📊 HOLD: TMDX shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

Adjust Growth Assumption: 25.0%

0% (Stagnation) 50% (Hyper Growth)

EST. PRICE IN 2031

$109.74

Based on 14.5% avg growth

INTRINSIC VALUE TODAY

$68.14

Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: TMDX is currently trading at $72.06, which is considered oversold relative to its 30-day fair value range of $76.77 to $86.44. The stock's valuation (Forward PE: 32.1) is in line with its historical norms (33.5). Remarkably, the market is currently pricing in an annual earnings decline of 1.4% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, TMDX is in a uptrend. Immediate support is located at $67.31, while resistance sits at $81.34.

Market Sentiment: TMDX scores 73/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $98.73 (+36.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position OVERSOLD

Historical Trading Range $76.77 - $86.44

Company Quality Score 63/100 (BUY)

Volume Confirmation HIGH

Confidence Score 90.5%

Protect Your Profits

Holding TMDX? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

BULLISH: Price oversold vs 30-day range
BULLISH: Strong technical setup (73/100)
BULLISH: High volume confirmation
BULLISH: Trading 36.4% below Wall St target ($98.73)
BULLISH: Bottoming setup score 73/100 — corrected, stabilizing, and turning up
CAUTION: Recommendation downgraded due to -5.8% 5-day decline

Trading Range Analysis

30-Day Trading Range $76.77 - $86.44

Current vs Trading Range OVERSOLD

Support & Resistance Levels

Support Level $67.31

Resistance Level $81.35

Current Trend Uptrend

Technical data as of Oct 22, 2026

Fundamental Context

Forward P/E (Next Year Est.) 32.12

Wall Street Target $98.73 (+36.4%)

Revenue Growth (YoY) 20.7%

Earnings Growth (YoY) -55.8%

Profit Margin 22.7%

Valuation Discount vs History -1.4% cheaper

PE vs Historical 32.1 vs 33.5 FAIR

Market-Implied Price Targets If current PE multiple persists

Implied Growth (YoY): -1.4% (market-implied from PE analysis)

1-Year Target $71.39 (-1%)

2-Year Target $70.39 (-3%)

3-Year Target $69.40 (-4%)

3-Yr Target (if PE normalizes) (PE: 32→34) $72.39 (0%)

3-Year Scenarios Using analyst projected EPS growth

Bull: (PE: 32.1, Growth: 49.0%) $239.44 (+231%)

Base: (SPY PE: 19.9, Growth: 49.0%) $148.06 (+105%)

Bear: (PE: 16.9, Growth: 49.0%) $125.85 (+74%)

📈 Valuation based on Current Earnings

Trailing PE: 18.55 | Current EPS (TTM): $4.03

Bull Case $45.99 (-37%)

Analyst growth -44.1%, PE expands to 20.4

Base Case $41.81 (-42%)

Market implied -44.1%, PE stable at 18.6

Bear Case $50.83 (-30%)

Severe decline -20.0%, PE contracts to 15.8

These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.

💡 Upside Surprise Potential

If earnings stabilize (0% growth), PE could expand from 32.1 to 33.5

Stabilization Target: $75.52 (+4.3%)

PE Expansion Potential: +4.3%

Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit

bloggers & journalists: you are free to use our charts with attribution.

Last updated: October 22, 2026 4:12 PM ET
Data refreshes hourly during market hours. Next update: 5:12 PM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is TMDX showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check

Insider Activity (6 Months)

Buys

Sells

Net

NEUTRAL

View Insider Activity Scanner

Unlock Insider Activity

See real-time buying/selling by company executives for TMDX.

Create Free Account

Already have an account? Log In

Top Rated Medical Devices Stocks

Top-rated stocks in Medical Devices by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
DXCM DexCom Inc	STRONG BUY 29 analysts	$96	45 HOLD
ABT Abbott Laboratories	STRONG BUY 28 analysts	$121	50 HOLD
EW Edwards Lifesciences Corp	STRONG BUY 29 analysts	$102	51 HOLD
SYK Stryker Corporation	STRONG BUY 29 analysts	$363	32 SELL
MDT Medtronic PLC	BUY 29 analysts	$105	44 HOLD

DXCM DexCom Inc

45 HOLD

ABT Abbott Laboratori…

50 HOLD

EW Edwards Lifescien…

51 HOLD

SYK Stryker Corporati…

32 SELL

MDT Medtronic PLC

44 HOLD

Advanced TMDX Option Strategies

Professional options setups generated by AI based on today's TMDX price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for TMDX

TMDX Technical Chart TMDX Price Prediction TMDX Earnings Date TMDX Investment Advisor TMDX Fair Price Analyzer TMDX Options Advisor TMDX Options Chain TMDX Options Analysis TMDX Competitors

Compare TMDX with Peers

TMDX vs OSCR
Which one to buy?

TMDX vs CELH
Which one to buy?

TMDX vs FOUR
Which one to buy?

TMDX vs DLO
Which one to buy?

TMDX vs CLPT
Which one to buy?

BRKR vs TMDX
Winner: TMDX

Create New Comparison View All Competitors

Tradestie